CHIME Opioid Task Force Playbook

CHIME Opioid Task Force Playbook

Publication date: May 27, 2019

The CHIME Opioid Task Force was launched in early 2018 with a straight-forward mission: to turn the tide on the opioid epidemic using the knowledge and expertise of the nation’s healthcare IT leaders. While our mission is straight-forward, achieving it is a complicated challenge. Opioid addiction is a complex disease that requires long-term, if not lifetime, care from well-informed clinicians who are supported with easy-to-use and reliable tools. The CHIME Opioid Playbook has been created by CIOs and CMIOs for CIOs and CMIOs to help them develop a program that will help their providers, healthcare organizations and especially patients be successful.

The playbook provides a framework to build IT-based supports for launching and maintaining system-wide initiatives to reduce the disease of opioid addiction in our communities. It is based on the knowledge, experience and insights from the diverse membership of CHIME and CHIME Foundation partners, with real-world examples, best practices and links to valuable resources. The playbook is tailored to CIOs and CMIOs who serve as members of their organization’s Opioid Stewardship Committee, but we expect that others will find it to be a useful guide to understanding technology’s role in creating a solution.

This playbook is a living document. It is designed to offer up-to-date IT-based leading practices for addressing opioid addiction. For instance, portions of this iteration of the playbook focus on reducing prescriptions of opioids to patients being seen in the hospital setting. By exposing fewer patients to opioids, or lessening exposure for those who will benefit from treatment, is likely to lessen the number of people who inadvertently become addicted. Later iterations may focus on the population of people who had become addicted and now need long-term care to help them remain addiction-free.

PDF

Concepts Keywords
Addiction Guide understanding technology
Analgesia Weaning protocols
Analgesic Business intelligence
Anesthesia Pain protocol
Benchmarking Pain management
Big Data Drug overdose
Change Management Opioid use disorder
CIO Euphoriants
Clinical Informatics Morphine
Dashboard Morphinans
EHR RTT
Enable Medicine
Foundation Hospital Health
Healthcare Opioids
High Fidelity Pain management
Holistic Treatment protocol
Hospital Surgery
Hospitalist Easy reliable tools
Informatics Public relations
Leadership Accountability Opioid management
Leverage Providers healthcare organizations
Multi Disciplinary Foundation hospital systems
Multimodal Applicable healthcare systems
Naloxone Development small product
Nursing Happen tool
Opioid Large healthcare systems
Opioid Addiction Large healthcare system
Opioid Epidemic Unproductive dialog systems
Opioids Healthcare leaders mission
Pain Experience organizations systems
Pain Management Organizational pain management
Patience Prescribers systems
Patient Advocate Hospitals systems
Pediatrics Vice president services
Peer Pressure Opioid pain management
Pennsylvania Guide understanding technology
Pharmacological Pain protocol
Pharmacy Communities
Physician
Prescription Drug
Primary Care
Prince Frederick
Psychiatry
Public Relations
Risk Assessment
Silver Bullet
Supply Chain
Tablets
The Message
Tide
Urgent Care
Weaning
Workflow

Semantics

Type Source Name
disease MESH suffering
gene UNIPROT RPL10
gene UNIPROT PLXNA1
gene UNIPROT CCN3
gene UNIPROT F11R
gene UNIPROT CD40LG
gene UNIPROT ACP5
gene UNIPROT TRAF2
gene UNIPROT SCYL1
gene UNIPROT TDRD7
drug DRUGBANK Benzodiazepine
drug DRUGBANK Acetaminophen
gene UNIPROT CHL1
gene UNIPROT THOP1
disease MESH visual
gene UNIPROT DYRK3
gene UNIPROT IK
gene UNIPROT LITAF
disease MESH satisfaction
gene UNIPROT TNFRSF11A
disease MESH development
gene UNIPROT WASF1
gene UNIPROT TIE1
gene UNIPROT MMP12
gene UNIPROT MME
drug DRUGBANK Morphine
gene UNIPROT GRASP
gene UNIPROT CEP55
gene UNIPROT BLOC1S4
gene UNIPROT CNOT8
drug DRUGBANK Etoperidone
disease MESH chronic pain
gene UNIPROT AIFM2
disease MESH diagnoses
gene UNIPROT LARGE1
drug DRUGBANK Naloxone
disease MESH Weaning
disease DOID analgesia
gene UNIPROT EHD1
disease MESH peer pressure
gene UNIPROT TNFSF13
gene UNIPROT ANP32B
drug DRUGBANK Silver
gene UNIPROT APP
gene UNIPROT RNMT
gene UNIPROT MET
gene UNIPROT SLTM
drug DRUGBANK Methionine
disease DOID opioid abuse
disease MESH opioid abuse
disease MESH Emergency
gene UNIPROT SSRP1
gene UNIPROT RASA1
gene UNIPROT RGS6
disease MESH multi
gene UNIPROT SMIM10L2A
gene UNIPROT SMIM10L2B
drug DRUGBANK Nonoxynol-9
drug DRUGBANK Spinosad
gene UNIPROT BEST1
disease MESH communities
gene UNIPROT KCNK3
gene UNIPROT PIGL

Similar

Download Document

Leave a Comment

Your email address will not be published. Required fields are marked *